We are proud to sponsor FDNA’s Year of Discovery again in May to accelerate advancements for patients with metabolic conditions

Published on April 27, 2017

FDNA’s Year of Discovery unites clinicians, labs and patients for rare disease advancements. Throughout the month of May, FDNA and Blueprint Genetics will be driving discoveries for metabolic conditions, including storage disorders. As part of the initiative, Blueprint Genetics has pledged a donation of up to $2,500 in May to benefit the National MPS Society.

Clinicians are invited to submit patient photos, diagnoses, and phenotypes to the HIPAA-compliant Face2Gene CLINIC system for analysis. “Having the patient’s photograph and comprehensive list of clinical findings and symptoms is really helpful in the interpretation of findings from genetic testing, especially for the larger gene panels and exome sequencing. Ability to submit this information to the interpretation team via Face2Gene would allow even better interpretation of the testing results.“ says Eveliina Salminen, M.D, Ph.D, Clinical Geneticist, Team leader for Interpretation Team, Blueprint Genetics.

Get Involved

Blueprint Genetics will match each case uploaded in May with a $1 donation to the National MPS Society, up to $2,500.

The Face2Gene deep learning technology will de-identify and analyze the shared cases to identify new phenotypes, facial characteristics and genes that are associated with rare diseases—advancing our understanding and hope for the future.

For Clinicians:

  1. Register for a free Face2Gene account at com or through the app on your mobile device
  2. Login
  3. Add a new case
  4. Upload the patient photo
  5. Enter the patient information and phenotypic traits
  6. Confirm the patient’s clinical and/or molecular diagnosis

Get a more detailed overview at www.Face2Gene.com/tutorial


In total Blueprint Genetics is sponsoring three months during the Year of Discovery:

May is the month for metabolic conditions

March – RASopathies
May – Metabolic conditions, including storage disorders
September – Craniosynostoses and Craniofacial conditions

The Year of Discovery initiative spotlights a different category of rare and genetic syndromes each month. See the entire discovery schedule and get involved at FDNA.com/YearOfDiscovery


Read more: FDNA Partners with Blueprint Genetics to Spotlight RASopathies During the Year of Discovery

Last modified: 09.05.2017


Blueprint Genetics strengthens its pharmaceutical expertise with new Chairman Hilde Furberg and by appointing Guido Oelkers as a Senior Advisor

Published on December 5, 2018

Blueprint Genetics has gained worldwide momentum and continued global growth in the field of clinical genetic testing of rare inherited diseases. As one of the fastest growing clinical genetic testing businesses globally, Blueprint Genetics has a customer base spanning more than 40 countries. Today, Blueprint Genetics is proud to announce…

Read more

Subscribe to our newsletter